The trademark application Closderive was filed by Swyssi, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 14, 2022, and it was registered by office on October 21, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Anticoagulants
Antihypertensives
Diuretic pharmaceutical preparations
Pharmaceutical preparations for the treatment of heart rhythm disorders
Cardiovascular drugs used in treating congestive heart failure (CHF)
Medicines for the treatment of cardiovascular and cerebrovascular diseases
Pharmaceutical preparations for the treatment of cardiovascular disease
Cardiovascular drugs used in myocardial infarction
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension.